RU2-70271-65418
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 371 / TN
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Swelling, Itching · Headache, Muscle or body achesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-07
-
2021-02-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-04
Health check-in — day 0, dose 2Feeling: Fair · Site: Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Tremor — Feeling: Fair · Site: Itching · Fever · Muscle or body aches, Fatigue or tirednessFree text: Dizziness and shakinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-11
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
-
2021-04-15
Survey response — day 42, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: GoodFree text: Heavy painful menstrual cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-09-02
- 2022-03-04
-
2022-07-30
Dose 3 — Pfizer-BioNTech
- 2022-07-30
-
2022-07-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2022-08-01
- 2022-08-02
- 2022-08-03
-
2022-08-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-08-05
- 2022-08-06
-
2022-08-13
Survey response — day 14, dose 3MedDRA: Headache, Pain, Pyrexia, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive for Covid, aches, fever, headache,MedDRA releases: 2024-11 · check-in free text available
-
2022-08-13
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-15
- 2022-08-21
- 2022-08-27
- 2022-09-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2022-07-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness and shakiness
Release 7 — day 42, dose 2
Symptoms: Heavy painful menstrual cycle
Release 12 — day 14, dose 3
Symptoms: Tested positive for Covid, aches, fever, headache,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release